Interleukin-2 in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00002746 · COMPLETED

Trial details

NCT number: NCT00002746
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 1996-01-01
Primary completion: 2004-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.